Jan. 13, 2018 – Neuros Medical Inc., a nerve stimulation company in Willoughby, has been able to measure the impact of its technology though studies. The most recent study showed that patients using its technology, which blocks the nerve transmission on demand with a high-frequency electrical signal, had about an 80% to 85% pain reduction rate and a 92% pill count reduction. As companies are bringing solutions to the market, it’s important that they’re not layering on cost to the health care system, said Jon Snyder, founder and chief business officer at Neuros.
Full Story @ CrainsCleveland.com
EMR MATTERS – October 2024 - The challenge is that many in the behavioral health…
TOO LITTLE, TOO LATE? – Dec. 19, 2024 - Assembly Bill 56 (AB 56) proposes…
AND STOPPED DIGGING – Dec. 4, 2024 - In a new interview with The Times,…
NOT JUST IN PENCILS – Dec. 8, 2024 - Americans born before 1966 experienced “significantly…
AS SUCCESSFUL AS EVER – Dec. 3, 2024 - Family Affair actor Johnny Whitaker looked…
ALANON Plus – Dec. 7, 2024 - A high percentage of treatment failures occur due…